The Motley Fool
18 Jul 2026, 10:48 UTC · 3h ago
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
The Motley Fool
18 Jul 2026, 10:48 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
The Invesco Nasdaq Biotechnology ETF (IBBQ) posted a one-year return of 48%, significantly outperforming the broader healthcare approach of IXJ. — Strong short-term performance in biotech suggests high risk appetite and growth momentum in the sector.
+0.40IBBQ exhibits significantly higher volatility than IXJ, with a five-year maximum drawdown of 38% compared to IXJ's 18%. — Highlights the substantial downside risk and volatility inherent in concentrated biotech investments compared to diversified healthcare.
-0.20The iShares Global Healthcare ETF (IXJ) offers a higher dividend yield of 1.47% compared to IBBQ's 0.79%. — Provides a modest positive for income-focused investors seeking stability over growth.
+0.10Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
Mentioned as a top holding and used as an example of a stable company, but no specific positive or negative news provided.
Mentioned only as a top holding in a healthcare ETF without a qualitative assessment of the company's performance.
Mentioned as a top holding and recommended by the author, but the text contains no news or analysis affecting its value.
Mentioned as a top holding and recommended by The Motley Fool, but no specific financial driver is discussed.
Mentioned as a top holding and recommended by The Motley Fool, but no specific catalysts are provided.
Mentioned as a top holding in a biotech ETF without specific company-level news.
[mutual] Both are biotechnology companies listed as top holdings in a concentrated biotech ETF.
[mutual] Both are biotechnology companies listed as top holdings in a concentrated biotech ETF.
[mutual] Both are biotechnology companies listed as top holdings in a concentrated biotech ETF.
[mutual] Both are large pharmaceutical makers categorized within the same healthcare sector exposure.
[mutual] Both are large pharmaceutical makers categorized within the same healthcare sector exposure.
[mutual] Both are large pharmaceutical makers categorized within the same healthcare sector exposure.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
55m ago
